Skip to content

Using Tea-based Mouthwash Relieve Stomatitis and Oral Ulcers

Using Tea-based Mouthwash Relieve Stomatitis and Oral Ulcers

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05010928
Enrollment
100
Registered
2021-08-18
Start date
2021-08-26
Completion date
2024-11-26
Last updated
2021-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomatitis

Keywords

Stomatitis; oral ulcers; oral mucosa; tea; mouthwash

Brief summary

The aim of this study is to use a tea-based mouthwash to relieve pain and discomfort in patients with stomatitis and ulcers.

Detailed description

The objective of this study is to use tea as a base, supplemented with licorice to reduce bitterness and astringency, to make mouthwash, and use tea's antioxidant and anti-inflammatory properties to relieve the pain and discomfort of stomatitis and ulcer patients. This study will observe the difference between saliva and oral mucosal cells before and after treatment, to find the mechanism of effective treatment of stomatitis.

Interventions

COMBINATION_PRODUCTmouthwash with tea

Using tea as a base, supplemented with licorice to make mouthwash to relieve stomatitis.

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

age over 20 years old, male or female

Exclusion criteria

patients with oral cavity cancer, oropharyngeal cancer, and active bacterial infection.

Design outcomes

Primary

MeasureTime frameDescription
Xerostomia questionnaire (XQ)4 weeksQuestionnaires for symptoms relief of dry mouth
Xerostomia Inventory (XI)4 weeksA multi-item approach to measuring dry mouth

Secondary

MeasureTime frameDescription
Rate of oral mucosa cells with angiotensin-converting enzyme 2 (ACE2) staining (+)4 weeksImmunohistochemistry stain for ACE2 protein

Countries

Taiwan

Contacts

Primary ContactMing-Shao Tsai, M.D.
b87401061@gmail.com+886 5 3621000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026